Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has been selected as winner of the “Best Patient Experience Solution” award in the 8th annual MedTech Breakthrough Awards program. MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.




The 2024 MedTech Breakthrough Award recognizes the breakthrough innovation of Orthofix’s STIM onTrack mobile app that tracks patient compliance data from their bone stimulation device, which is prescribed after a fracture injury, lumbar or cervical fusion.

The STIM onTrack mobile app works with the latest generation CervicalStim, SpinalStim, and PhysioStim bone growth therapy devices. These devices are approved by the FDA and provide patients with a safe and effective nonsurgical treatment to improve nonunion fractures and spinal fusion healing. By providing a hyper-targeted experience, the mobile app addresses unique patient needs related to bone healing.

Featuring daily treatment reminders and device usage calendars, patients can stay on schedule with their treatments. The mobile app also allows patients to fill out patient reported outcome measures and submit pain scores and transmit them to their physicians, allowing for remote monitoring in between appointments.

The STIM onTrack app also provides links to educational patient resources and connects patients with Orthofix’s Patient Care team to help ensure patients understand their treatment regimens.

“We are extremely honored to be recognized for the second year in a row as a winner of the Medtech Awards – this year for Best Patient Experience Solution,” said Jason Shallenberger, President of Bone Growth Therapies. “Orthofix was the first company in this space to recognize the importance of patient engagement in their own recovery by utilizing our STIM onTrack app. This allows patients to report a variety of information back to their physician such as pain scores and treatment compliance among other things.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and Privacy, and many more. This year’s program attracted thousands of nominations from over 18 different countries throughout the world.

“The STIM onTrack mobile app provides tools designed to help patients adhere to their prescriptions and improve their clinical outcomes. Patients who take an active role in their follow-up care have a better overall recovery experience and more optimal outcomes,” said Steve Johansson, managing director, MedTech Breakthrough. “By allowing patients to remotely share their data and recovery updates, Orthofix is delivering a much-needed solution that supports physician remote patient monitoring endeavors, and aids in improving overall patient experience and outcomes.”

About Orthofix

Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in more than 60 countries worldwide.

The Company is headquartered in Lewisville, Texas, where it conducts general business, product development, medical education and manufacturing, and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. Orthofix’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Maidenhead, UK, Munich, Germany, Paris, France and São Paulo, Brazil.

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

Contacts

Media Relations
Denise Landry

DeniseLandry@orthofix.com
214.937.2529

Investor Relations
Louisa Smith, Gilmartin Group

IR@orthofix.com

Staff

Recent Posts

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey’s…

3 hours ago

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

AUSTIN, Texas--(BUSINESS WIRE)--Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships…

3 hours ago

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

6 hours ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

6 hours ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

6 hours ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

9 hours ago